MDS with 5q deletion and rare


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
20 Apr 2019
Historique:
entrez: 22 4 2019
pubmed: 22 4 2019
medline: 4 9 2019
Statut: epublish

Résumé

A patient with a diagnosis of myelodysplastic syndrome (MDS) with isolated 5q deletion underwent repeat bone marrow biopsy to assess haematological response after 6 months of initial lenalidomide therapy. Subsequent bone marrow biopsies revealed persistent MDS with del(5q) in addition to a small atypical mast cell population with >25% of mast cells with spindle-shaped morphology and immunohistochemistry characteristics consistent with mastocytosis. Molecular testing on the bone marrow was positive for

Identifiants

pubmed: 31005862
pii: 12/4/e227768
doi: 10.1136/bcr-2018-227768
pmc: PMC6506002
pii:
doi:

Substances chimiques

Immunologic Factors 0
Lenalidomide F0P408N6V4

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Int J Hematol Oncol Stem Cell Res. 2017 Jul 1;11(3):231-239
pubmed: 28989590
Front Med (Lausanne). 2017 Jul 20;4:110
pubmed: 28775983
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Blood. 2009 Oct 29;114(18):3769-72
pubmed: 19713463
Am J Hematol. 2016 Nov;91(11):1146-1159
pubmed: 27762455
Blood. 2009 Apr 23;113(17):3947-52
pubmed: 18987358
Arch Pathol Lab Med. 2012 Jul;136(7):832-8
pubmed: 22742558
Pathology. 2012 Aug;44(5):492-3
pubmed: 22777071
Leuk Res. 2007 Feb;31(2):261-5
pubmed: 16876862
Leukemia. 2015 May;29(5):1115-22
pubmed: 25567135

Auteurs

Daniel Steven Sanders (DS)

Department of Internal Medicine, McLaren-Oakland Hospital, Pontiac, Michigan, USA.

Thomas Fennell (T)

Department of Pathology, Oakland University William Beaumont Hospital, Royal Oak, Michigan, USA.

Mohammad Muhsin Chisti (MM)

Department of Hematology and Medical Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH